Preparing for a Consumer-Driven Genomic Age.
The above article is published in this week's New England Journal of Medicine. It's a very good overview of the issues that we face in exploiting the power of genomics without exploiting the consumer by offering unvalidated and essentially meaningless test results. In addition to the issues raised in the article, it's worth noting that the CLIA regulations still do not have a separate specialty called Genetics that covers the very unique technical challenges of performing testing on nucleic acids using technologies that didn't exist when the regulations came into effect nearly 20 years ago.
The above article is published in this week's New England Journal of Medicine. It's a very good overview of the issues that we face in exploiting the power of genomics without exploiting the consumer by offering unvalidated and essentially meaningless test results. In addition to the issues raised in the article, it's worth noting that the CLIA regulations still do not have a separate specialty called Genetics that covers the very unique technical challenges of performing testing on nucleic acids using technologies that didn't exist when the regulations came into effect nearly 20 years ago.
